ARTHUR J. KLAUSNER - 02 Feb 2022 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Director
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-fact
Issuer symbol
MNPR
Transactions as of
02 Feb 2022
Transactions value $
$0
Form type
4
Filing time
04 Feb 2022, 18:30:54 UTC
Previous filing
04 Jan 2022
Next filing
01 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +15.1K $0.00 15.1K 02 Feb 2022 Common Stock 15.1K $2.80 Direct F1
transaction MNPR Restricted Stock Units Award $0 +11.4K $0.00 11.4K 02 Feb 2022 Common Stock 11.4K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022.
F2 RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022.